SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs > MannKind Corp. (MNKD)

On Facebook:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
WHS Member Profile
 
Followed By 3
Posts 445
Boards Moderated 0
Alias Born 12/01/15
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/11/2017 8:32:40 AM
MannKind Responds to Hurricane Harvey Devastation with Afrezza® Donation "GlobeNewswire Inc." - 9/7/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/6/2017 4:33:29 PM
MannKind Corporation Relocates Headquarters to Westlake Village "GlobeNewswire Inc." - 9/5/2017 9:00:00 AM
MannKind Corporation to Present at Upcoming Conferences "GlobeNewswire Inc." - 9/1/2017 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 7:10:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 7:10:22 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 7:09:36 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/23/2017 7:08:31 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/11/2017 6:19:11 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/7/2017 4:09:41 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 4:07:56 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/7/2017 4:07:34 PM
MannKind Corporation Reports 2017 Second Quarter Financial Results "GlobeNewswire Inc." - 8/7/2017 4:05:00 PM
MannKind and One Drop Partner to Launch the A-ONE Clinical Trial "GlobeNewswire Inc." - 8/7/2017 9:30:00 AM
MannKind and One Drop Partner to Launch the A-One Clinical Trial "PR Newswire (US)" - 8/7/2017 6:30:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/25/2017 4:46:43 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 7/25/2017 4:45:53 PM
MannKind Corporation to Hold 2017 Second Quarter Financial Results Conference Call on August 7, 2017 "GlobeNewswire Inc." - 7/25/2017 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/17/2017 4:47:35 PM
Steven Binder Joins MannKind as Chief Financial Officer "GlobeNewswire Inc." - 7/17/2017 9:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/17/2017 6:02:58 AM
Patrick McCauley Joins MannKind as Chief Commercial Officer "GlobeNewswire Inc." - 7/12/2017 9:00:00 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 7/3/2017 6:11:17 AM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 7/3/2017 6:11:17 AM
WHS   Saturday, 05/20/17 12:14:16 AM
Re: None
Post # of 25375 
On Facebook:

Vdex Diabetes added 4 new photos.
27 mins ·

We are pleased to announce the opening of our new dedicated facility in Canoga Park where previously we had an office share arrangement. With this new medical facility we will be able to deliver a higher standard of care, and better help patients manage their diabetes.

Our experience to date has shown us the need for a new and better approach. Currently, the management of diabetes is based on outdated protocols, resulting in less-than-ideal outcomes. In addition, doctors' facilities simply are not conducive to an effective patient experience with respect to diabetes. Now, with Vdex, patients will have the most up-to-date treatment protocols together with an office experience built around the idea of producing demonstrably better control of blood sugar.

Through the protocols we've established and implemented with our initial group of patients, we've been able to safely lower HBa1c to levels that were previously unattainable. In some cases, we've seen patients reach HbA1c levels that are physiologically non-diabetic, with no increased risk of hypoglycemia. In fact, we've seen hypoglycemic risk fall at the same time as HbA1c is brought down, something most physicians would say is impossible. We have made extensive use of a new medication, Afrezza, and our conclusion is that we can change the diabetes landscape forever through the use of this medication. We are so confident in this medication, that we believe it really should be the first medication for the treatment of diabetes, assuming the patient meets the necessary criteria.
We invite you to our June 1st grand opening event where we will be giving away a 2 week continuous monitoring trial (normal value, more than$500) to three lucky winners. All you have to do is RSVP using the link below with your Name, Email address and Phone number.

Vdex Diabetes
21201 Victory Blvd #265
Canoga Park, CA 91367
vdexopening@vdexdiabetes.com



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist